ÂÜÀòÂÒÂ×

Krista Daniel is a scientist with extensive experience in small molecule drug discovery and a focus on investigating glycolysis for anti-cancer drug development. Currently employed at Bonito Biosciences since April 2024 and Catamaran Bio since March 2022, Krista previously held roles including Senior Research Associate at TScan Therapeutics and Associate Scientist at bluebird bio. Academic experience includes serving as a Graduate Student Research Assistant at the University of Connecticut and a Teaching Assistant, where responsibilities encompassed lectures, grading, and student support. Krista's early research involved assessing neuronal cell viability at Seton Hall University, complemented by roles as an Office Assistant and Library Technician. Educational background includes a Master of Science in Cell/Cellular and Molecular Biology from the University of Connecticut and a Bachelor of Science in Biology from Seton Hall University.